Pelion Poland

In 1990, just as Poland enters the free-market economy, an important part of the country’s history, Jacek Szwajcowski and Zbigniew Molenda founded Medicines, a pharmaceutical wholesaler. The company was renamed as Pelion in 2014.

In 1998, the business was quoted on the Warsaw Stock Exchange, becoming the first pharmaceutical group to be listed publicly. 

In 1999, the company entered a merger with one of the largest pharmaceutical distributors in the hospital market in the country, Urtica. 

In 2004, Medicines entered the retail market in Poland and operated its stores under 3 banners:

DOZ Apteki

DOZ Drogerie

Natura beauty stores

The business also entered the Lithuanian market under the banners:

Gintarine Vaistine

Norfos Vaistine

Limedika

In 2011, following a reorganisation, Pelion classified its businesses into 4 distinct areas:

Hospital  Sales

Retail Sales

Wholesale

Services for manufacturing

The company operates more than 840 branches of its own and franchises as well. 

Pelion Poland achieves a turnover of over €2 billion each year and currently employs over 10,000 people.

Pelion was awarded the CSR Silver Leaf in 2017 and as from 2011, it was included in the Respect Index for 5 consecutive years. Pelion also won the Oar of Business statute in 2015. 

The business operates a warehouse of 105000 m2. 

In 2019, Pelion invested € 47 million in expansion, innovation and energy efficient improvement. Furthermore, the firm also announced that additional investments would be made in order to upgrade its warehouse and its stores.